MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, TELO has $7,341,361 in assets. $1,427,991 in debts.

Balance Sheets Overview

Current Ratio
514.10%
Quick Ratio
514.10%
Debt to Asset Ratio
19.45%
Unit: Dollar
Assets Breakdown
    • Cash
    • Prepaid expenses
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Trade accounts payable and accru...
    • Others

Balance Sheets
2025-12-31
Cash
7,286,670
Prepaid expenses
54,691
Total current assets
7,341,361
Total assets
7,341,361
Trade accounts payable and accrued liabilities
536,769
Due to officer
155,518
Accrued compensation - officer
417,470
Due to related parties
318,234
Total current liabilities
1,427,991
Total liabilities
1,427,991
Additional paid-in capital
46,923,433
Accumulated deficit
-41,010,063
Total stockholders equity
5,913,370
Total liabilities and stockholders equity
7,341,361
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$7,286,670 Prepaid expenses$54,691 Total current assets$7,341,361 Total assets$7,341,361 Total liabilities andstockholders equity$7,341,361 Total stockholdersequity$5,913,370 Total liabilities$1,427,991 Accumulated deficit-$41,010,063 Additional paid-in capital$46,923,433 Total currentliabilities$1,427,991 Trade accountspayable and accrued...$536,769 Accrued compensation -officer$417,470 Due to relatedparties$318,234 Due to officer$155,518

Telomir Pharmaceuticals, Inc. (TELO)

Telomir Pharmaceuticals, Inc. (TELO)